Santyl

Type: Product
Name: Santyl
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

Update: BioSpecifics Technologies Earnings

Summary BioSpecifics reported second quarter 2014 total revenue of $2.7 million, a decrease of 19% year-over-year. Net income came in at $0.6 million or $0.09 per basic share, compared to net income of $1.0 million or $0.16 per basic share in the year-ago ... [Published Seeking Alpha - Aug 15 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

LYNBROOK, N.Y., Aug. 11, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published TickerTech.com - Aug 11 2014]

Quotes

...Thomas L Wegman, President of BioSpecifics, said, "This was a momentous quarter of milestones for XIAFLEX both commercially and clinically. We saw significant growth in revenues from XIAFLEX U S sales, most notably in Peyronie's disease. We are particularly pleased to see the number of vials shipped in the second quarter of 2014; 565 in April, 775 in May and then almost double that number in June with 1,412 vials shipped. This was a significant increase over the first quarter shipments of 598 vials."
"With the financial benefit realized from this commercial success, we maintain the ability to progress our proprietary pipeline. We were very excited to report last week the initiation of our Phase 2 clinical trial of CCH in human patients with lipoma. The data we reported in January were very promising and we hope to duplicate these positive results and progress this indication towards commercialization. We also submitted the final study report to Auxilium for CCH in canine lipoma, to which we will await their decision on whether to in-license this indication, making it the fifth indication within our development agreement."

More Content

All (3) | News (3) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Update: BioSpecifics Technologies Earnings [Published Seeking Alpha - Aug 15 2014]
BioSpecifics Technologies Corp. Reports Second ... [Published TickerTech.com - Aug 11 2014]
PM360 Announces Winners of 2013 Pharma Choice A... [Published PRWeb - Jan 23 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.